期刊
GYNECOLOGICAL ENDOCRINOLOGY
卷 37, 期 6, 页码 558-561出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/09513590.2020.1832066
关键词
Aryl hydrocarbon receptor repressor; endocrine disruptor; glutathione-S-transferase polycystic ovary syndrome; polymorphism
资金
- Seoul National University Hospital Research Fund [04-2017-0370]
The study found that the combination of AhRR CG or GG and GSTT1 null genotype, or the combination of GSTM1/GSTM1 null genotype, may be associated with an increased risk of PCOS, but there was no significant association between the combination of AhRR and GSTM1.
Objective To investigate the association between the aryl hydrocarbon receptor repressor (AhRR) C/G polymorphisms and glutathione-S-transferase M1 (GSTM1) and GSTT1 null mutation and the risk of polycystic ovary syndrome (PCOS) in Korean women. Methods This was a case-control study of 478 women with PCOS and 376 aged-matched healthy controls. Genotyping of the AhRR C/G polymorphism and GSTM1 and GSTT1 were performed using real-time PCR analysis and multiplex PCR, respectively. Results The genotype distribution of the AhRR C/G polymorphisms and GSTM1/GSTT1 null mutations did not differ between women with PCOS and controls. Using the wild-type combined AhRR CC and GSTT1 present genotype as a reference, the odds that a woman had PCOS were 1.54 (95% CIs 1.04-2.29) times higher if she had a combined AhRR CG or GG and GSTT1 null genotype. The odds that a woman had PCOS was 1.48 (95% CIs 1.08-2.04) times higher if she had a combined GSTM1/GSTT1 null genotype compared with the wild-type combined GSTM1/GSTT1 present genotype. However, there were no significant associations between the risk of PCOS and any combined AhRR and GSTM1. Conclusions Our data suggest that a combined AhRR CG or GG and GSTT1 null genotype or a combined GSTT1/GSTM1 null genotype might be associated with an increased risk of PCOS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据